Detalhe da pesquisa
1.
Engineering Rapalog-Inducible Genetic Switches Based on Split-T7 Polymerase to Regulate Oncolytic Virus-Driven Production of Tumour-Localized IL-12 for Anti-Cancer Immunotherapy.
Pharmaceuticals (Basel);
16(5)2023 May 07.
Artigo
em Inglês
| MEDLINE
| ID: mdl-37242495
2.
Oncolytic virus driven T-cell-based combination immunotherapy platform for colorectal cancer.
Front Immunol;
13: 1029269, 2022.
Artigo
em Inglês
| MEDLINE
| ID: mdl-36405739